Stocks News

LAST PRICE
85.4300
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
71.0000/ 1
Ask / Lots
86.3900/ 1
Open / Previous Close
--- / 85.4300
Day Range
---
52 Week Range
Low 70.2500
High 97.9700
Volume
362
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 15, 2024
- DJ Haemonetics Price Target Maintained With a $112.00/Share by Needham, from 2:30PM ET on Friday Nov 15, 2024 by Dow Jones
  2:30PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: HAE
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HAE/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 14:30 ET (19:30 GMT)
Nov 8, 2024
- DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 4:22PM ET on Friday Nov 08, 2024 by Dow Jones
  4:22PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: HAE
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HAE/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 16:22 ET (21:22 GMT)
- DJ Haemonetics Raised to Strong Buy From Outperform by Raymond James, from 7:04AM ET on Friday Nov 08, 2024 by Dow Jones
  7:04AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: HAE
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HAE/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 07:04 ET (12:04 GMT)
Nov 7, 2024
- Haemonetics Fiscal Q2 Adjusted Earnings, Revenue Rise, from 8:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  8:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: HAE
  08:53 AM EST, 11/07/2024 (MT Newswires) -- Haemonetics (HAE) reported fiscal Q2 adjusted earnings Thursday of $1.12 per diluted share, up from $0.99 a year earlier. Analysts polled by Capital IQ expected $1.07. Net revenue for the quarter ended Sept...
- Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by PR Newswire
  6:00AM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: HAE
  Financial release accessible online
  Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are available on its Investor Relations website.

Nov 14, 2024
- LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: LIVN
Nov 13, 2024
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: GH
- DJ ICU Medical Is Maintained at Overweight by Keybanc, from 10:33AM ET on Wednesday Nov 13, 2024 by Dow Jones
  10:33AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ICUI
Nov 12, 2024
- ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised, from 5:15PM ET on Tuesday Nov 12, 2024 by MT Newswires
  5:15PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ICUI
- -- Earnings Flash (ICUI) ICU MEDICAL Posts Q3 EPS $1.59, from 4:17PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:17PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ICUI
- -- Earnings Flash (ICUI) ICU MEDICAL Reports Q3 Revenue $589.1M, from 4:16PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:16PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ICUI
- ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America, from 4:05PM ET on Tuesday Nov 12, 2024 by PR Newswire
  4:05PM ET on Tuesday Nov 12, 2024 by PR Newswire
  Companies Mentioned: ICUI
- ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ICUI
- *DJ ICU Medical 3Q Loss/Shr $1.35 >ICUI, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ICUI
- ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ICUI

Haemonetics Corp
NYSE:HAEUnited States

Search Criteria

Nov 15, 2024

DJ Haemonetics Price Target Maintained With a $112.00/Share by Needham, from 2:30PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 8, 2024

DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 4:22PM ET on Friday Nov 08, 2024 by Dow Jones

DJ Haemonetics Raised to Strong Buy From Outperform by Raymond James, from 7:04AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Haemonetics Fiscal Q2 Adjusted Earnings, Revenue Rise, from 8:53AM ET on Thursday Nov 07, 2024 by MT Newswires

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by PR Newswire

Peers Headlines

Nov 14, 2024

LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ ICU Medical Is Maintained at Overweight by Keybanc, from 10:33AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised, from 5:15PM ET on Tuesday Nov 12, 2024 by MT Newswires

-- Earnings Flash (ICUI) ICU MEDICAL Posts Q3 EPS $1.59, from 4:17PM ET on Tuesday Nov 12, 2024 by MT Newswires

-- Earnings Flash (ICUI) ICU MEDICAL Reports Q3 Revenue $589.1M, from 4:16PM ET on Tuesday Nov 12, 2024 by MT Newswires

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America, from 4:05PM ET on Tuesday Nov 12, 2024 by PR Newswire

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

*DJ ICU Medical 3Q Loss/Shr $1.35 >ICUI, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones